Advertisement
Screener

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Overview

NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.72; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual -0.42; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.05; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -0.37; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$1.40$1.81$2.34$3.03$3.92$5.072025-09-292026-09-29$1.40$2.25$3.63$5.85$9.43$15.192021-09-292026-09-29$1.40$2.38$4.06$6.92$11.79$20.112016-09-292026-09-29$1.40$2.38$4.06$6.92$11.79$20.112006-09-292026-09-29$1.12$2.12$4.02$7.61$14.42$27.301993-10-282026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.47
Previous close
$1.70
Change
-$0.23
Change (%)
-13.53%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

NAII
-58.94%
S&P 500
(m)

1 year

NAII
-49.48%
S&P 500
(m)

3 years

NAII
-77.35%
S&P 500
(m)

5 years

NAII
-89.32%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual -0.72

-0.80-0.57-0.33-0.100.1331 Dec 2024: estimate (m); actual -0.3731 Dec 2024(m)31 Mar 2025: estimate (m); actual -0.3731 Mar 2025(m)30 Sept 2025: estimate (m); actual -0.0530 Sept 2025(m)31 Dec 2025: estimate (m); actual -0.4231 Dec 2025(m)31 Mar 2026: estimate (m); actual -0.7231 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)-0.72(m)(m)
1 Oct 202531 Dec 2025(m)-0.42(m)(m)
1 Jul 202530 Sept 2025(m)-0.05(m)(m)
1 Jan 202531 Mar 2025(m)-0.37(m)(m)
1 Oct 202431 Dec 2024(m)-0.37(m)(m)

30 Jun 2025 ○ Estimate (m) ● Actual -2.28

-2.36-1.29-0.220.851.9230 Jun 2021: estimate (m); actual 1.6930 Jun 2021(m)30 Jun 2022: estimate (m); actual 1.7430 Jun 2022(m)30 Jun 2023: estimate (m); actual 0.4330 Jun 2023(m)30 Jun 2024: estimate (m); actual -1.2330 Jun 2024(m)30 Jun 2025: estimate (m); actual -2.2830 Jun 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jul 202430 Jun 2025(m)-2.28(m)(m)
1 Jul 202330 Jun 2024(m)-1.23(m)(m)
1 Jul 202230 Jun 2023(m)0.43(m)(m)
1 Jul 202130 Jun 2022(m)1.74(m)(m)
1 Jul 202030 Jun 2021(m)1.69(m)(m)

Revenue vs. Earnings

USD

31 Dec 2018 ■ Revenue 36.04M ■ Earnings 2.18M — Profit margin 6.05%

-5.86M-5.0%9.78M-0.6%25.43M3.7%41.07M8.0%31 Dec 2017: revenue 33.34M; earnings -1.32M; profit margin -3.95%31 Dec 201731 Mar 2018: revenue 31.82M; earnings 2.05M; profit margin 6.45%31 Mar 201830 Sept 2018: revenue 36.53M; earnings 2.56M; profit margin 7.00%30 Sept 201831 Dec 2018: revenue 36.04M; earnings 2.18M; profit margin 6.05%31 Dec 2018

30 Jun 2018 ■ Revenue 132.44M ■ Earnings 5.05M — Profit margin 3.81%

-15.89M2.8%38.85M5.0%93.59M7.2%148.33M9.4%30 Jun 2015: revenue 79.51M; earnings 3.35M; profit margin 4.21%30 Jun 201530 Jun 2016: revenue 114.20M; earnings 9.55M; profit margin 8.36%30 Jun 201630 Jun 2017: revenue 121.95M; earnings 7.24M; profit margin 5.93%30 Jun 201730 Jun 2018: revenue 132.44M; earnings 5.05M; profit margin 3.81%30 Jun 2018

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.47(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.47High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning NAII

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
215.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
16.75K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-22.63%*
Total return · month
-31.94%*
Total return · quarter
-38.49%*
Total return · half year
-47.31%*
Total return · year to date
-58.94%*
Total return · 1 year
-49.48%*
Total return · 3 years
-77.35%*
Total return · 5 years
-89.32%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

NATURAL ALTERNATIVES INTERNATIONAL INC Overview

View more →

(m)

(m)

SEC CIK
787253
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Country of operation
United States
Business address
1535 FARADAY AVENUE, CARLSBAD, California, 92008-7319, United States
Fiscal year end
0630
Phone
7607367700

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87